EVT-801

N/A

Report date: 2025/01/02 16:12:09
NMEFirst In Class

Base Information

Drug NameEVT-801
Drug Alias NameEVT-801
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVascular endothelial growth factor receptor 3 antagonists
TargetsVascular endothelial growth factor receptor 3
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSanofi Sa (Sanofi Ag)
China Registration ClassN/A

Develop Information

Active CompaniesKazia TherapeuticsKazia Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A